Search

everythinglearnresearchcommunity

for

Search:↓

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

We need safe, affordable drugs to fight coronaviruses effectively.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

The treatment might help COVID-19 related hair loss, but more research is needed.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

A young Russian girl with Meier-Gorlin syndrome has two new mutations in the CDC6 gene.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Combining FTSC with TSN6 peptide greatly improves wound healing.

Lung microbiome research is growing, focusing more on specific mechanisms and clinical uses.

Long COVID sufferers face significant challenges that need more public awareness and support.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Severe hair loss significantly worsens quality of life.

Thyroid dysfunction can cause heart issues, and bedside ultrasound helps diagnose cardiac arrest causes.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Oxyresveratrol promotes hair growth and may help treat hair loss.